A Collection of Articles
Edit

Biomedicine

Melanoma Monitor

  • December 20, 2011

It can be difficult for dermatologists to correctly identify early-stage skin cancer. To assist them, this device uses a multispectral camera to peer below the skin surface. Using a database of lesions for comparison, the system can recommend that a mole be biopsied. Its accuracy rate is higher than that of a standard examination alone.

Product: MelaFind
Cost: $7,500:
Availability: Now
Source: www.melasciences.com
Companies: Mela Sciences

You've read of free articles this month.